Takeda Pharmaceutical Company
AskBiography Logo   Latest News  Follow Us on Twitter  Follow Us on Google Buzz  Became Fan - Facebook  Subscribe to RSSRSS   Bookmark and Share

Takeda Pharmaceutical Company

Company nameTakeda Pharmaceutical Company Limited
Company typePublic (Tyo - 4502)
IndustryPharmaceuticals
Founded1781
HeadquartersOsaka, Japan
Key peopleKunio Takeda, Chairman
Yasuchika Hasegawa, President
Revenue(+)$15,697 billion USD (FY 2008)
Net income(+)$2,392 billion USD (FY 2008)
Employees19,362 (2008)

     Home | Company | Takeda Pharmaceutical Company



|} (Tyo - 4502) is the largest pharmaceutical company in Japan and Asia and a top 15 pharmaceutical company, employing over 19,000 employees and achieving $15.7 billion USD in revenue during the 2008 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary Millennium: The Takeda Oncology Company.

Latest News : Takeda Pharmaceutical Company : Tweet this RSS

Pfizer Heads BMI's Asia Pharmaceutical Sales Ranking For Q210 - Pharmaceuticals & Healthcare Insight (registration) Tweet this news
Pharmaceuticals & Healthcare Insight (registration)--From BMI's selection of 12 multinational -pharmaceutical companies-, -Takeda- generates the greatest proportion of total revenue in Asia. ... - Date : Wed, 11 Aug 2010 05:38:34 GMT+00:00
Reportlinker Adds Takeda Pharmaceutical Co. Ltd: PharmaVitae Profile - MarketWatch (press release) Tweet this news
MarketWatch (press release)--This analysis examines the historical and forecast performance for -Takeda- in the prescription -pharmaceutical- sector. The profile encompasses global -company- ... - Date : Tue, 10 Aug 2010 13:06:28 GMT+00:00
Global Sleeping Pills Market to Reach US$9.0 billion by 2015, According to New ... - PR Web (press release) Tweet this news
PR Web (press release)--Major players profiled in the report include Sanofi-Aventis, Sepracor, King Pharmaceuticals, H. Lundbeck A/S, -Takeda Pharmaceutical Company-, ... - Date : Mon, 09 Aug 2010 07:27:36 GMT+00:00
Sucampo losses widen - Bizjournals.com Tweet this news
Bizjournals.com--The results were effected by a drop in research and development revenue payments from -Takeda Pharmaceutical- Co., which is funding Phase 3 trials of ... - Date : Fri, 06 Aug 2010 16:18:18 GMT+00:00
Sucampo Pharmaceuticals Reports Second Quarter 2010 Financial Results - MarketWatch (press release) Tweet this news
MarketWatch (press release)---...- by -Takeda Pharmaceutical Company- (Takeda) as well as reduced revenue recognized under the agreement with Abbott related to Amitiza development in Japan. ... - Date : Thu, 05 Aug 2010 20:07:07 GMT+00:00
Alexza sinks on offering; Affymax rallies - MarketWatch Tweet this news
MarketWatch--Affymax and partner -Takeda Pharmaceutical- Co. said that they hope to file for US regulatory approval for their drug candidate Hematide during the first half ... - Date : Thu, 05 Aug 2010 14:28:11 GMT+00:00
Affymax and Takeda Announce Preliminary US Registration Strategy for ... - StreetInsider.com (subscription) Tweet this news
StreetInsider.com (subscription)--Located in Osaka, Japan, -Takeda- is a research-based global -company- with its main focus on pharmaceuticals. As the largest -pharmaceutical company- in Japan ... - Date : Thu, 05 Aug 2010 09:06:23 GMT+00:00
Affymax and Takeda Announce Preliminary U.S. Registration Strategy for ... - MarketWatch (press release) Tweet this news
MarketWatch (press release)--Affymax, Inc. Sylvia Wheeler, 650-812-8861 Vice President, Corporate Communications or -Takeda Pharmaceutical Company- Limited Seizo Masuda, +1 81-3-3278-2037 ... - Date : Thu, 05 Aug 2010 09:06:57 GMT+00:00
Seoul to invite 100 world CEOs to G20 summit - AFP Tweet this news
AFP---...- received from CEOs of the largest -companies- in a particular field in each continent or nation, including HSBC, -Takeda Pharmaceutical-, Deutsche Bank, ... - Date : Thu, 05 Aug 2010 07:17:02 GMT+00:00
Seattle Genetics Expands Antibody-Drug Conjugate Collaboration with Genentech - MarketWatch (press release) Tweet this news
MarketWatch (press release)--Brentuximab vedotin is being developed in collaboration with Millennium: The -Takeda- Oncology -Company-. In addition, Seattle Genetics has five other ... - Date : Tue, 03 Aug 2010 11:06:36 GMT+00:00

JP TOPIX 100 companies of Japan

Core 307&i * Astellas * Canon * Honda * JFE * JR East * JT * KDDI * KEPCO * Komatsu * Mitsubishi Corporation * Mitsubishi Estate * Mitsui & Co. * Mizuho * MUFG * Nintendo * Nippon Steel * Nissan * Nomura * NTT * NTT docomo * Panasonic * Shin-Etsu * Sony * Sumitomo Mitsui Financial * Takeda * TEPCO * Tokio Marine * Toshiba * Toyota
Large 70ÆON * AGC * Asahi Kasei * Bank of Yokohama * Bridgestone * Chubu Electric Power * Daiichi Sankyo * Daikin * Daiwa House * Daiwa Securities * Denso * DNP * Eisai * FANUC * Fujifilm * Fujitsu * Hitachi * Hoya * INPEX * Itochu * JR Central * JR West * Kao * Keyence * Kirin * Kobelco * Kubota * Kyocera * Kyushu Electric Power * Marubeni * Mitsubishi Chemical * Mitsubishi Electric * Mitsubishi Heavy Industries * Mitsui Fudosan * MOL * MSIG * Murata * NEC * Nidec * Nikon * Nippon Oil * Nitto Denko * ORIX * Resona * Ricoh * Rohm * Secom * Sekisui House * Sharp * Shiseido * SMC * SoftBank * Sompo Japan * Sumitomo Chemical * Sumitomo Corporation * Sumitomo Electric * Sumitomo Metal Mining * Sumitomo Metals * Sumitomo Realty * Sumitomo Trust * Suzuki * T&D * TDK * Tohoku Electric Power * Tokyo Electron * Tokyo Gas * Toppan * Toray * Yahoo! Japan * Yamada Denki



Privacy | Sitemap